NEWS10 ABC: Albany, New York News, Weather, SportsPrescription drug abuse crisis

Prescription drug abuse crisis

Posted:

ALBANY, NY - The New York State Senate discussed on Monday illegal prescription drug abuse.

According to Senator Hannon, abuse of controlled prescription drugs is one of New York's major public health problems and is growing at an alarming rate.

The roundtable featured discussion and input from parents of victims whose deaths were attributed to prescription drug abuse, stirring emotions as parents talked about this problem.

Overdose deaths from prescription pain killers have reached epidemic proportions in the United States. The Center for Disease Controls and Prevention report that more people die from prescription drug overdoses than heroin or cocaine combined.

Senate Majority Leader Dean G. Skelos says, "We are seeing our young people die from prescription overdoses and others committing horrific crimes to obtain pain killers. We have to update our laws to prevent more tragedies from happening and punish those who illegally make these drugs available."

Prescriptions for Oxycodone, Hydrocodone and Tramadol have increased among abused drugs. They are second to marijuana abuse.

Lawmakers are consider a number of options to help decrease this issue. Some options discussed in the meeting were the following:

- Place greater controls on Hydrocodone and Tramadol, highly addictive prescription pain medications

- Increase criminal penalties for physicians and pharmacists who illegally divert prescription drugs

- Criminalize the illegal sale of a controlled substance by a practitioner or pharmacist to address practitioners operating "pill mills", which fuel the black market for controlled substance medication

- Criminalize the first-degree illegal sale of a controlled substance to a minor under the age of 14, making it a Felony

Powered by WorldNow
     
NEWS10 ABC
341 Northern Boulevard
Albany, NY 12204
+(518) 436-4822
Powered by WorldNow
All content © Copyright 2000 - 2012 WorldNow and WTEN. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.